Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene

Journal of Pharmacological Sciences

Volumn 97, Issue 1, 2005, Pages 43-51

  Nishinaka, Toru ^a   Yabe Nishimura, Chihiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Aldo keto reductase; Aldose reductase; Antioxidant response element; AP1; Nrf2

Indexed keywords

ALDEHYDE REDUCTASE; BETA NAPHTHOFLAVONE; MESSENGER RNA; TRANSCRIPTION FACTOR NRF2;

AKR1B3 GENE; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL STRAIN HEPG2; DRUG METABOLISM; ENZYME INDUCTION; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONTROL; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 14644397287     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FP0040404     Document Type: Article

References (41)

1. Jez JM, Flynn TG, Penning TM. A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol. 1997;54: 639-647.
2. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev. 1998;50:21-33.
3. Yagihashi S. Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models. J Peripher Nerv Syst. 1997;2:113-132.
4. Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim Biophys Acta. 1991;1078:171-178.
5. He Q, Khanna P, Srivastava S, Van KF, Ansari NH. Reduction of 4-hydroxynonenal and 4-hydroxyhexenal by retinal aldose reductase. Biochem Biophys Res Commun. 1998;247:719-722.
6. Kolb NS, Hunsaker LA, Vander Jagt DL. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. Mol Pharmacol. 1994;45:797-801.
7. Sato S, Sugiyama K, Carper D. Aldose reductase as dihydrodiol dehydrogenase: naphthoquinone formation by rat lens aldose reductase. Adv Exp Med Biol. 1997;414:499-505.
8. Vander JD, Kolb NS, Vander JT, Chino J, Martinez FJ, Hunsaker LA, et al. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta. 1995;1249:117-126.
9. Hsu D, Guo Y, Peifley KA, Winkles JA. Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress. Biochem J. 1997;328:593-598.
10. Chang KC, Paek KS, Kim HJ, Lee YS, Yabe-Nishimura C, Seo HG. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol. 2002;61:1184-1191.
11. Ko B, Ruepp B, Bohren KM, Gabbay KH, Chung SS. Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J Biol Chem. 1997;272:16431-16437.
12. Lopez RC, Aramburu J, Rakeman AS, Rao A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci USA. 1999;96:7214-7219.
13. Miyakawa H, Woo SK, Dahl SC, Handler JS, Kwon HM. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity [see comments]. Proc Natl Acad Sci USA. 1999;96:2538-2542.
14. Iwata T, Sato S, Jimenez J, McGowan M, Moroni M, Dey A, et al. Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem. 1999;274:7993-8001.
15. Li H, Nobukuni Y, Gui T, Yabe-Nishimura C. Characterization of genomic regions directing the cell-specific expression of the mouse aldose reductase gene. Biochem Biophys Res Commun. 1999;255:759-764.
16. Nishinaka T, Yabe-Nishimura C. EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic Biol Med. 2001;31:205-216.
17. Nakamura N, Obayashi H, Fujii M, Fukui M, Yoshimori K, Ogata M, et al. Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products. Free Radic Biol Med. 2000;29:17-25.
18. Seo HG, Nishinaka T, Yabe-Nishimura C. Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Mol Pharmacol. 2000;57:709-717.
19. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991;266:11632-11639.
20. Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol. 1995;15:4184-4193.
21. Wasserman WW, Fahl WE. Functional antioxidant responsive elements. Proc Natl Acad Sci USA. 1997;94:5361-5366.
22. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236:313-322.
23. Nguyen T, Huang HC, Pickett CB. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J Biol Chem. 2000;275:15466-15473.
24. Jiang ZQ, Chen C, Yang B, Hebbar V, Kong AN. Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. Life Sci. 2003;72:2243-2253.
25. Moinova HR, Mulcahy RT. Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem Biophys Res Commun. 1999;261:661-668.
26. Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, et al. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem. 2000;275: 27694-27702.
27. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002;62:5196-5203.
28. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem. 2003; 278:12029-12038.
29. Daoudal S, Tournaire C, Halere A, Veyssiere G, Jean C. Isolation of the mouse aldose reductase promoter and identification of a tonicity-responsive element. J Biol Chem. 1997; 272:2615-2619.
30. Iwata T, Minucci S, McGowan M, Carper D. Identification of a novel cis-element required for the constitutive activity and osmotic response of the rat aldose reductase promoter. J Biol Chem. 1997;272:32500-32506.
31. Nishimura C, Matsuura Y, Kokai Y, Akera T, Carper D, Morjana N, et al. Cloning and expression of human aldose reductase. J Biol Chem. 1990;265:9788-9792.
32. Nishinaka T, Fu YH, Chen Ll, Yokoyama K, Chiu R. A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1. Biochim Biophys Acta. 1997;1351:274-286.
33. Wasserman WW, Fahl WE. Comprehensive analysis of proteins which interact with the antioxidant responsive element: correlation of ARE-BP-1 with the chemoprotective induction response. Arch Biochem Biophys. 1997;344:387-396.
34. Wild AC, Moinova HR, Mulcahy RT. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem. 1999;274:33627-33636.
35. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76-86.
36. Friling RS, Bergelson S, Daniel V. Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene. Proc Natl Acad Sci USA. 1992;89:668-672.
37. Favreau LV, Pickett CB. The rat quinone reductase antioxidant response element. Identification of the nucleotide sequence required for basal and inducible activity and detection of anti-oxidant response element-binding proteins in hepatoma and non-hepatoma cell lines. J Biol Chem. 1995;270:24468-24474.
38. Keightley JA, Shang L, Kinter M. Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection. Mol Cell Proteomics. 2004;3:167-175.
39. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53:615-627.
40. Lee KW, Ko BC, Jiang Z, Cao D, Chung SS. Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer. Drugs. 2001;12:129-132.
41. Morimitsu Y, Nakagawa Y, Hayashi K, Fujii H, Kumagai T, Nakamura Y, et al. A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem. 2002;277:3456-3463.